Toogood G J, Roake J A, Morris P J
Nuffield Department of Surgery, John Radcliffe Hospital, Headington, Oxford, U.K.
Clin Transplant. 1994 Aug;8(4):373-7.
In the past, fever has been considered to be an important sign of rejection in renal transplant patients but since the introduction and widespread use of cyclosporin this relationship has become less clear. We have studied the relationship between fever defined as a single temperature reading > or = 38.5 degrees C or recordings > or = 38.0 degrees C over 2 consecutive days, and acute rejection or infection in 99 consecutive renal transplants. Within the first 6 months after transplantation 90 acute rejection episodes were recorded in 61 patients and most (83%) were not associated with fever. Forty-seven episodes of fever were documented in 37 patients and ascribed to acute rejection (15), infection (17), antibody therapy (11) or other causes (4). Fever in the first 16 days was significantly more likely to be due to rejection than to infection (chi 2 = 24.47, p = < 0.001). Episodes of fever due to infection tended to occur after the 1st month, coincident with the peak incidence of cytomegalovirus (CMV) infection. However, with the exception of CMV disease, fever was not a reliable guide for the presence of infection, including septicemia.
过去,发热一直被视为肾移植患者排斥反应的一个重要体征,但自从环孢素问世并广泛应用以来,这种关系已变得不那么明确。我们研究了在99例连续肾移植中,将发热定义为单次体温读数≥38.5℃或连续两天体温记录≥38.0℃与急性排斥反应或感染之间的关系。在移植后的前6个月内,61例患者记录到90次急性排斥反应发作,其中大多数(83%)与发热无关。37例患者记录到47次发热发作,病因分别为急性排斥反应(15次)、感染(17次)、抗体治疗(11次)或其他原因(4次)。移植后前16天内的发热更有可能是由排斥反应而非感染引起(卡方检验=24.47,p<0.001)。由感染引起的发热发作往往发生在第1个月之后,与巨细胞病毒(CMV)感染的高发期相符。然而,除了CMV疾病外,发热并不是包括败血症在内的感染存在的可靠指标。